Re: "A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer".

por Bradlow, H L, Kabat, G C
Publicado 1998

Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.

por Telang, N T, Katdare, M, Bradlow, H L, Osborne, M P
Publicado 1997

Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer.

por Davis, D L, Telang, N T, Osborne, M P, Bradlow, H L
Publicado 1997

Effects of pesticides on the ratio of 16 alpha/2-hydroxyestrone: a biologic marker of breast cancer risk.

por Bradlow, H L, Davis, D L, Lin, G, Sepkovic, D, Tiwari, R
Publicado 1995

Medical hypothesis: xenoestrogens as preventable causes of breast cancer.

por Davis, D L, Bradlow, H L, Wolff, M, Woodruff, T, Hoel, D G, Anton-Culver, H
Publicado 1993

Alteration of oestradiol metabolism in myc oncogene-transfected mouse mammary epithelial cells.

por Telang, N. T., Arcuri, F., Granata, O. M., Bradlow, H. L., Osborne, M. P., Castagnetta, L.
Publicado 1998

Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up.

por Meilahn, E. N., De Stavola, B., Allen, D. S., Fentiman, I., Bradlow, H. L., Sepkovic, D. W., Kuller, L. H.
Publicado 1998

Quantifying estrogen metabolism: an evaluation of the reproducibility and validity of enzyme immunoassays for 2-hydroxyestrone and 16alpha-hydroxyestrone in urine.

por Ziegler, R G, Rossi, S C, Fears, T R, Bradlow, H L, Adlercreutz, H, Sepkovic, D, Kiuru, P, Wahala, K, Vaught, J B, Donaldson, J L, Falk, R T, Fillmore, C M, Siiteri, P K, Hoover, R N, Gail, M H
Publicado 1997